ActiGraft is an FDA-cleared regenerative wound care solution that enables health care providers to produce in real-time in vitro blood clot tissue from a patient's whole blood. Once applied, the blood clot tissue serves as a protective covering, biologic scaffold, and wound microenvironment to promote the natural wound healing processes of the body.
ActiGraft can be used for a wide variety of hard-to-treat chronic wounds, including but not limited to diabetic/neuropathic ulcers, pressure ulcers/injury, venous stasis ulcers, post-surgical wounds, traumatic wounds, and skin tears.
ActiGraft supports each stage of the wound healing process and delivers significant benefits in terms of comfort, effectiveness, and cost.
Covers the wound for long periods of time with minimal care between applications.
Can be easily prepared at the patient s bedside in 8 minutes and requires no capital equipment.
Created from the patient s blood, assuring the safe and effective management of the wound.
EASE OF PAIN
Minimal handling of the wound provides a more comfortable treatment for patients.